Last reviewed · How we verify
NCT02902562: CEUS
Synovitis and Therapy Response in Inflammatory Arthritis With Contrast Enhanced Ultrasound
NA trial testing Contrast Enhanced Ultrasound (CEUS) in Synovitis in 16 participants. Completed in 22 August 2018.
17 July 2018
Quick facts
| Lead sponsor | University of Southern California |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 16 |
| Start date | 31 August 2016 |
| Primary completion | 17 July 2018 |
| Estimated completion | 22 August 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Contrast Enhanced Ultrasound (CEUS) — full drug profile →
- Magnetic Resonance Imaging (MRI)
Conditions studied
- Synovitis — all drugs for Synovitis →
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
Sponsor
University of Southern California
Who can join
18 and older, any sex, with Synovitis or Rheumatoid Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study is about using contrast-enhanced ultrasound (CEUS) to assess the degree of synovitis (joint inflammation) in patients with inflammatory arthritis, such as rheumatoid arthritis, and whether it can be used for assessing a treatment response. The investigators hope to learn whether contrast enhanced ultrasounds are better than regular imaging techniques, such as MRI, when used to evaluate the response to disease modifying anti-rheumatic drug (DMARD) therapy in inflammatory arthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT02902562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Contrast Enhanced Ultrasound (CEUS)
Trials testing the same drug.
- NCT06775977 — Ultrasound Contrast-Enhanced Accurate Diagnosis of Preoperative Staging of Bladder Cancer · recruiting
- NCT03963999 — Validating Ultrasound Biomarkers for Hepatic Sinusoidal Obstruction Syndrome in Pediatric Hematopoietic Cell Transplant · Phase 4 · withdrawn
Other recruiting trials for Synovitis
Currently open trials in the same condition.
- NCT05700682 — Perfusion MRI-targeted Joint Embolization for Chronic Musculoskeletal Pain of the Shoulder, Hip and Knee · recruiting
- NCT05629130 — Embolization in Hereditary Coagulopathies · NA · recruiting
- NCT04641351 — Corticosteroid Meniscectomy Randomized Trial · Phase 4 · active not recruiting
Other University of Southern California trials
Trials by the same sponsor.
- NCT07288463 — Hearing Loss and Genetic Risks for Alzheimer's Disease and Related Dementia · NA · not yet recruiting
- NCT05914233 — Non-invasive Ultrasound Retinal Stimulation for Vision Restoration · NA · not yet recruiting
- NCT06163664 — Role of ChatGPT in Vestibular Schwannoma Management · NA · withdrawn
- NCT07332312 — A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Ind · NA · not yet recruiting
- NCT07290478 — Encouraging Older Adults and Adults With Serious Illness to Designate a Health Care Proxy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02902562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Southern California
- Last refreshed: 17 April 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02902562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing